ChoA Pharmaceutical KRX:034940KOSDAQ

조아제약 · Korean news coverage and regulatory filings, organized.

Articles, 24h0
Articles, 7 days0
DART filings, 7 days0
Articles tracked28since Sep 11

In Q2 2026, ChoA Pharmaceutical reported revenue of ₩15.2bn, up 11.3% year on year, and an operating loss of ₩23m. ChoA Pharmaceutical (조아제약) appeared in 0 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 20 with 5 articles. It was most often mentioned alongside IL Dong Pharmaceutical, Hwail Pharm and Samik Pharm.

Filing signals 4 quarters of losses Screener

ChoA Pharmaceutical quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩15.2bn+11.3%−₩23m
margin −0.2%
₩377m
Q1 2026₩14.7bn+2.1%−₩1.1bn
margin −7.6%
−₩150m
Q4 2025 derived₩15.8bn-7.0%−₩1.5bn
margin −9.5%
−₩3.2bn
Q3 2025₩15.5bn+1.6%−₩1.5bn
margin −9.6%
−₩415m
Q2 2025₩13.6bn-10.9%−₩1.5bn
margin −11.0%
−₩1.6bn
Q1 2025₩14.4bn-5.0%−₩2.1bn
margin −14.7%
−₩2.2bn
Q4 2024 derived₩17.0bn+7.8%−₩3.4bn
margin −20.2%
−₩4.1bn
Q3 2024₩15.2bn+2.9%−₩2.7bn
margin −17.7%
−₩2.8bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

ChoA Pharmaceutical top stories 2 weeks, by number of outlets

  1. 1
    조아제약, 특허 균주 함유 '데일리 프로바이오틱스 이뮨' 출시
    2 outlets · 2 articlesFirst report Oct 20 07:31 메디파나뉴스
  2. 2
    조아제약, 장 건강·면역기능 관리 유산균 선봬…100억 CFU 함유
    1 outlets · 1 articlesFirst report Oct 20 08:27 PRESS9
  3. 3
  4. 4
    제약업종株 혼조세…삼익제약 웃고 화일약품·조아제약 휘청
    1 outlets · 1 articlesFirst report Oct 20 10:41 핀포인트뉴스Samik PharmHwail Pharm
  5. 5

Latest ChoA Pharmaceutical news Korean headlines